PharmaCyte Biotech Inc (PMCB)

[takeyouhigher]

As I said, cisplatin is not in the comparator arm. The combination that adds cisplatin has already been shown to be superior (at ASCO) to the gemcitabine/nab-paclitxael combo.

Objective: Trial will be designed to show Cell-in-a-Box® + low-dose ifosfamide can serve as an effective and safe consolidation chemotherapy for patients whose tumors no longer respond to the therapy of Abraxane® + gemcitabine or FOLFIRINOX